epirubicin has been researched along with Kidney Neoplasms in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (23.33) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartnik, E; Bielecka, ZF; Brodaczewska, KK; Czarnecka, AM; Maliszewska-Olejniczak, K; Porta, C; Szczylik, C | 1 |
| Guo, X; Jiao, S; Jing, F; Li, J; Linghu, R; Liu, M; Yang, J; Zhu, Y | 1 |
| Boorjian, SA; Lu, DD; Raman, JD | 1 |
| De Kraker, J; Dijkgraaf, MG; Heij, H; Jagt, CT; Taminiau, JA; Ten Kate, F; Verschuur, AC; Zuckermann, M | 1 |
| Chou, YH; Huang, CH; Ke, HL; Li, CC; Wu, WJ; Yang, YH | 1 |
| Nieder, AM | 1 |
| Inui, M; Jin, C; Jin, X; Kakehi, Y; Sugimoto, M; Wu, XX | 1 |
| Antonuzzo, A; Chioni, A; Conte, P; Francesca, F; Galli, L; Iannopollo, M; Orlandini, C; Ricci, S; Selli, C; Vocaturo, V | 1 |
| Kakehi, Y; Ogawa, O; Wu, XX | 1 |
| Chen, WM; Cheng, CL; Ho, HC; Su, CK; Wang, SS; Yang, CR | 1 |
| Gao, XK; Kang, FX; Li, Q; Shao, GX; Wang, H; Yang, B; Yuan, JL | 1 |
| Huang, Y; Li, MJ; Liang, JF; Tang, DX; Tang, HF; Zhou, YB | 1 |
| Fujikawa, N; Hattori, Y; Kakizoe, M; Kishida, T; Kondo, K; Kubota, Y; Nakaigawa, N; Noguchi, K; Saito, K; Takizawa, A; Teranishi, J | 1 |
| Ganzina, F | 1 |
| Ahmed, T; Benedetto, P; Needles, B; Watson, RC; Yagoda, A | 1 |
| Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Bae, E; Fosså, SD; Lien, HH; Wik, B | 1 |
| Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
| Arai, Y; Kakehi, Y; Kanba, T; Shichiri, Y; Yoshida, O; Yoshida, S | 1 |
| Grossman, HB; Hamada, M; Koyanagi, T; Nonomura, K; Shinohara, N; Takakura, F | 1 |
| Casadio, M; Guaraldi, M; Lelli, G; Martoni, A; Panetta, A; Pannuti, F; Tamberi, S | 1 |
| Kobayashi, H; Obata, K | 1 |
| Senft, M; Strnad, V | 1 |
| Akyüz, C; Berberoğlu, S; Büyükpamukçu, M | 1 |
| Moriguchi, R; Nishizawa, K; Tanaka, M; Watanabe, S | 1 |
| Hasegawa, S; Kikuchi, E; Miyakita, M; Shimizu, K; Tanomogi, H; Yamataka, K | 1 |
| Kakehi, Y; Mizutani, Y; Ogawa, O; Wu, XX; Yoshida, O | 1 |
| Cersosimo, RJ; Hong, WK | 1 |
| Aeikens, B; de Riese, W; Lenis, G; Schindler, E | 1 |
| Akaza, H; Isaka, S; Ishikawa, H; Koiso, K; Koyanagi, T; Maru, A; Niijima, T; Sakashita, S; Shimazaki, J; Uchida, K | 1 |
4 review(s) available for epirubicin and Kidney Neoplasms
| Article | Year |
|---|---|
Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclobutanes; Deoxycytidine; Docetaxel; Epirubicin; Female; Fluorouracil; Giant Cells; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Organoplatinum Compounds; Prognosis; Retrospective Studies; Taxoids | 2014 |
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Chemical Phenomena; Chemistry; Colonic Neoplasms; Dogs; Doxorubicin; Epirubicin; Female; Heart; Humans; Kidney Neoplasms; Male; Melanoma; Mutagenicity Tests; Neoplasms, Experimental; Rabbits | 1983 |
[Mucinous adenocarcinoma of the renal pelvis: a case report].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Kidney; Kidney Calculi; Kidney Neoplasms; Kidney Pelvis; Ultrasonography; Urography | 1997 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
3 trial(s) available for epirubicin and Kidney Neoplasms
| Article | Year |
|---|---|
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dose-Response Relationship, Drug; Epirubicin; Female; Gemcitabine; Humans; Infusions, Intravenous; Injections, Intravenous; Kidney Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2002 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
23 other study(ies) available for epirubicin and Kidney Neoplasms
| Article | Year |
|---|---|
Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
Topics: Biomarkers, Tumor; Biomimetics; Carcinoma, Renal Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; Doxycycline; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Laminin; Neoplasm Metastasis; Neoplastic Stem Cells; Phenotype; Spheroids, Cellular; Sunitinib | 2019 |
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Humans; Instillation, Drug; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephroureterectomy; Oncologists; Perioperative Care; Retrospective Studies; Surveys and Questionnaires; Thiotepa; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2017 |
Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis.
Topics: Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Doxorubicin; Epirubicin; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Kidney Neoplasms; Liver; Male; Neoadjuvant Therapy; Nephrectomy; Postoperative Complications; Retrospective Studies; Ultrasonography; Wilms Tumor | 2009 |
Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Retrospective Studies; Time Factors; Ureter; Ureteral Neoplasms; Young Adult | 2010 |
Editorial comment.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Nephrectomy; Postoperative Care; Ureter; Ureteral Neoplasms | 2010 |
Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
Topics: Anthracyclines; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Caspases; Cell Line, Tumor; Doxorubicin; Drug Synergism; Epirubicin; Humans; Kidney Neoplasms; Polymerase Chain Reaction; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2012 |
Sensitization of human renal cell carcinoma cell lines to TRAIL-induced apoptosis by anthracyclines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Renal Cell; Cell Line, Tumor; Epirubicin; Humans; Kidney Neoplasms; Membrane Glycoproteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Seeding of malignant renal tumor through a nephrostomy tract.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Epirubicin; Female; Humans; Kidney; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Seeding; Neoplasms, Squamous Cell; Nephrostomy, Percutaneous; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Antisense oligonucleotide targeting survivin induces apoptosis of renal clear-cell carcinoma cells and enhances their sensitivity to epirubicin in vitro].
Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Epirubicin; Humans; Inhibitor of Apoptosis Proteins; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Proteins; Oligonucleotides, Antisense; Survivin; Transfection | 2005 |
[Treatment of advanced Wilms' tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Infant; Iodized Oil; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Preoperative Care; Survival Rate; Treatment Outcome; Vincristine; Wilms Tumor | 2006 |
[Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Organoplatinum Compounds; Quality of Life; Remission Induction; Survival Rate; Urinary Bladder Neoplasms | 2007 |
Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia | 1983 |
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia | 1984 |
Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Kidney Neoplasms; Middle Aged; Neoplasm Metastasis | 1982 |
Intra-arterial infusion chemotherapy in combination with a biscoclaurine alkaloid, Cepharanthin, to treat bone metastasis arising from renal cell carcinoma.
Topics: Alkaloids; Angiography; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Biopsy; Bone Neoplasms; Carcinoma, Renal Cell; Epirubicin; Humans; Ilium; Injections, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vinblastine | 1994 |
Expression of multidrug resistance gene product (P-glycoprotein) in transitional cell carcinomas of the upper urinary tract.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Female; Follow-Up Studies; Gene Expression; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Ureteral Neoplasms; Vinblastine | 1994 |
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Recombinant Proteins; Survival Rate; Vinblastine | 1994 |
[Radiochemotherapy in the treatment of metastatic renal cell carcinoma].
Topics: Aged; Carcinoma, Renal Cell; Combined Modality Therapy; Epirubicin; Humans; Kidney Neoplasms; Male | 1993 |
Successful treatment of intracaval and atrial extension of Wilms' tumour by chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Heart Atria; Humans; Kidney Neoplasms; Male; Neoplasm Invasiveness; Vena Cava, Inferior; Vincristine; Wilms Tumor | 1996 |
[A case of surgical resection for metachronous multiple liver metastases of chromophobe cell renal carcinoma].
Topics: Carcinoma, Renal Cell; Embolization, Therapeutic; Epirubicin; Female; Hepatectomy; Humans; Iodized Oil; Kidney Neoplasms; Liver Neoplasms; Middle Aged | 1998 |
Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
Topics: Acridine Orange; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Carcinoma, Renal Cell; Caspase 3; Caspases; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Epirubicin; fas Receptor; Fluorescent Dyes; Fluorouracil; Humans; Immunohistochemistry; Interferon-alpha; Interferon-gamma; Kidney Neoplasms; Lymphocytes, Tumor-Infiltrating; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vinblastine | 2000 |
[In vitro sensitivity testing of human kidney tumors to cytostatic drugs with a rapid in vitro test].
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Humans; Kidney Neoplasms; Mitomycin; Mitomycins; Tumor Stem Cell Assay; Vincristine | 1986 |
[Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Topics: Aged; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Hemoglobins; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Kidney Pelvis; Leukopenia; Male; Middle Aged; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1986 |